Discover
PLSE
Pulse Biosciences, Inc.
41.51
1 x 41.36
1 x 42.49
bid
ask
-
0.90
2.12%
undefined @ 04:00 PM
41.36 -0.15 (0.36%)
| Ytd | 202.33% | |
| 1y | 182.19% |
40.68
day range
43.52
12.56
52 week range
45.90
| Open | 43.13 | Prev Close | 42.41 | Low | 40.68 | High | 43.52 | Mkt Cap | 2.87B |
| Vol | 486.68K | Avg Vol | 384.67K | EPS | -1.10 | P/E | -37.74 | Forward P/E | -36.72 |
| Beta | 1.58 | Short Ratio | 8.38 | Inst. Own | 12.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 28.91 | 200-d Avg | 20.89 | 1yr Est | 41.00 |
| Income Statement | |||
| Total Revenue | 401.00K | ||
| Revenues (USD) | 401.00K | ||
| Cost of Revenue | 370.00K | ||
| Gross Profit | 31.00K | ||
| Operating Expenses | 19.18M | ||
| Research and Development Expense | 12.59M | ||
| Selling, General and Administrative Expense | 6.59M | ||
| Operating Income | -19.15M | ||
| Net Income | -18.58M | ||
| Net Income Common Stock | -18.58M | ||
| Net Income Common Stock (USD) | -18.58M | ||
| Consolidated Income | -18.58M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -18.58M | ||
| Earning Before Interest & Taxes (USD) | -18.58M | ||
| Weighted Average Shares | 67.99M | ||
| Weighted Average Shares Diluted | 67.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 68.32M | ||
| Cash and Equivalents (USD) | 68.32M | ||
| Trade and Non-Trade Receivables | 157.00K | ||
| Current Assets | 71.13M | ||
| Property, Plant & Equipment Net | 6.72M | ||
| Total Assets | 81.62M | ||
| Debt Current | 1.63M | ||
| Total Debt | 7.16M | ||
| Current Liabilities | 9.80M | ||
| Debt Non-Current | 5.53M | ||
| Total Liabilities | 15.32M | ||
| Accumulated Retained Earnings (Deficit) | -481.86M | ||
| Shareholders Equity | 66.30M | ||
| Shareholders Equity (USD) | 66.30M | ||
| Assets Non-Current | 10.49M | ||
| Total Debt (USD) | 7.16M | ||
| Goodwill and Intangible Assets | 3.20M | ||
| Inventory | 206.00K | ||
| Liabilities Non-Current | 5.53M | ||
| Trade and Non-Trade Payables | 2.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 563.00K | ||
| Net Cash Flow from Financing | 2.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.42M | ||
| Capital Expenditure | -33.00K | ||
| Issuance (Purchase) of Equity Shares | 2.27M | ||
| Net Cash Flow from Investing | -33.00K | ||
| Net Cash Flow from Operations | -14.59M | ||
| Share Based Compensation | 1.91M | ||